Pharma News

Ulixacaltamide by Praxis Precision Medicines for Essential Tremor: Likelihood of Approval

Ulixacaltamide is under clinical development by Praxis Precision Medicines and currently in Phase III for Essential Tremor.

Source link
#Ulixacaltamide #Praxis #Precision #Medicines #Essential #Tremor #Likelihood #Approval

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *